RxDoctor Payments Data

Timothy Light, DO

Family Medicine · Clearwater, FLNPI 1912215807

Payments from drug & device makers

$10,077in general payments, 2019–2025

Across 454 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$2K
  • Lilly USA, LLC$924
  • AbbVie$894
  • Novo Nordisk$733
  • GSK$693
  • Pfizer$559
  • plus $4K from 39 others

What the payments were for

  • Travel & lodging$1,69917%
  • Food & beverage$8,37983%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,077 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$213,827
Medicare patients
491
Services billed
2,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$61,074
OzempicSemaglutide29$42,813
XareltoRivaroxaban29$31,160
JardianceEmpagliflozin19$25,943
CreonLipase/Protease/Amylase13$18,923
WegovySemaglutide14$18,224
FarxigaDapagliflozin Propanediol13$17,235
MounjaroTirzepatide16$16,930
VeltassaPatiromer Calcium Sorbitex11$11,660
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$9,509
Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine16$7,793
OxycontinOxycodone Hcl11$6,594
SymbicortBudesonide/Formoterol Fumarate11$5,872
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$4,999
VascepaIcosapent Ethyl13$4,317

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$559$61,07462 claims
Novo NordiskOzempic, Wegovy$733$61,03743 claims
Johnson & JohnsonXarelto$262$31,16029 claims
Boehringer IngelheimJardiance$234$25,94319 claims
AstraZenecaFarxiga, Symbicort$366$23,10824 claims
AbbVieCreon, Synthroid$894$21,20338 claims
Lilly USA, LLCMounjaro$924$16,93016 claims
GSKAnoro Ellipta$693$9,50912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →